Tue, May 18, 2021

Scott Henry Maintained (VVOS) at Strong Buy with Decreased Target to $275 on, May 18th, 2021

Scott Henry of Roth Capital, Maintained "Vivos Therapeutics, Inc." (VVOS) at Strong Buy with Decreased Target from $300 to $275 on, May 18th, 2021.

Scott, nor any peers, have made any analyst calls on VVOS in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30